glp-1 news today 2025-10-16 Pharmacy Pricing Update (Dec 2025) GLP-1 Drugs: 6 Things We've

Recent Findings Observational studies and continuous glucose monitoring (CGM) reports reveal a high prevalence of hypoglycemia in post-bariatric pregnancies, ranging from 50% to 58%

Three reviews examined the effect of semaglutide on MASLD, most indicating a significant reduction in HFC with MD from 4.96 to 11.4

For any clinical purpose, tesamorelin wins on evidence

For most healthy adults, early antioxidant changes show up within 2 to 4 weeks

In a phase III randomized controlled trial, 966 patients with mild-to-moderate MASH (stage F1b, F2 or F3) were randomly assigned to once-daily oral treatment with 80 mg or 100 mg resmetirom or placebo for 52 weeks 4

This interplay highlights how antitrust law can indirectly influence deal structuring in healthcare since market share and competition issues loom larger in these booming therapeutic categories